X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2024-11-01 | HRMY | Valor IV Pharma Holdings, LLC | 10% | S - Sale | $30.30 | -4,600,000 | 6,618,033 | -41% | -$139,391,500 | |||||
M | 2024-11-01 | HRMY | Marshman Fund Trust II | 10% | S - Sale | $30.30 | -4,600,000 | 6,051,120 | -43% | -$139,391,500 | |||||
D | 2024-10-29 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $40.47 | -21,496 | 0 | -100% | -$870,018 | |||||
D | 2024-10-01 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $40.19 | -400 | 0 | -100% | -$16,077 | |||||
D | 2024-09-30 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $40.03 | -35,846 | 0 | -100% | -$1,434,951 | |||||
D | 2024-09-27 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $40.05 | -200 | 0 | -100% | -$8,009 | |||||
D | 2024-03-15 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $32.00 | -11,979 | 0 | -100% | -$383,328 | |||||
D | 2024-03-08 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $32.00 | -194 | 0 | -100% | -$6,208 | |||||
2022-12-14 | HRMY | Nielsen Jack | Dir | S - Sale | $59.96 | -2,834 | 2,571,024 | 0% | -$169,927 | ||||||
M | 2022-12-12 | HRMY | Wicki Andreas | Dir | S - Sale | $60.31 | -28,841 | 2,147,943 | -1% | -$1,739,342 | |||||
M | 2022-12-07 | HRMY | Nielsen Jack | Dir | S - Sale | $60.16 | -110,751 | 2,573,858 | -4% | -$6,662,698 | |||||
2022-12-05 | HRMY | Wicki Andreas | Dir | S - Sale | $61.23 | -77,853 | 2,176,784 | -3% | -$4,766,939 | ||||||
D | 2022-12-02 | HRMY | Serafin Andrew | CHIEF STRATEGY OFFICER | S - Sale+OE | $60.13 | -38,000 | 0 | -100% | -$2,285,100 | |||||
M | 2022-11-29 | HRMY | Nielsen Jack | Dir | S - Sale | $59.29 | -129,652 | 2,684,609 | -5% | -$7,686,960 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |